These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1104 related articles for article (PubMed ID: 3011306)
1. Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell lines. Eisman JA; Frampton RJ; McLean FJ Cell Biochem Funct; 1986 Apr; 4(2):115-22. PubMed ID: 3011306 [TBL] [Abstract][Full Text] [Related]
2. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Koga M; Eisman JA; Sutherland RL Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Frampton RJ; Omond SA; Eisman JA Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514 [TBL] [Abstract][Full Text] [Related]
4. 1 alpha, 25-Dihydroxyvitamin D3 specifically induces its own metabolism in a human cancer cell line. Eisman JA; Sher E; Suva LJ; Frampton RJ; McLean FL Endocrinology; 1984 Apr; 114(4):1225-31. PubMed ID: 6323135 [TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
6. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714 [TBL] [Abstract][Full Text] [Related]
7. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Eisman JA; Barkla DH; Tutton PJ Cancer Res; 1987 Jan; 47(1):21-5. PubMed ID: 3024816 [TBL] [Abstract][Full Text] [Related]
8. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor. Dokoh S; Donaldson CA; Haussler MR Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995 [TBL] [Abstract][Full Text] [Related]
9. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells. Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350 [TBL] [Abstract][Full Text] [Related]
10. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Hosoi J; Abe E; Suda T; Kuroki T Cancer Res; 1985 Apr; 45(4):1474-8. PubMed ID: 2983883 [TBL] [Abstract][Full Text] [Related]
11. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668 [TBL] [Abstract][Full Text] [Related]
12. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells. Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799 [TBL] [Abstract][Full Text] [Related]
13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Norman AW; Sergeev IN; Bishop JE; Okamura WH Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333 [TBL] [Abstract][Full Text] [Related]
14. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation. Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905 [TBL] [Abstract][Full Text] [Related]
15. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Miller GJ; Stapleton GE; Ferrara JA; Lucia MS; Pfister S; Hedlund TE; Upadhya P Cancer Res; 1992 Feb; 52(3):515-20. PubMed ID: 1370648 [TBL] [Abstract][Full Text] [Related]
16. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells. Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118 [TBL] [Abstract][Full Text] [Related]
17. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time. Okuno S; Inaba M; Nishizawa Y; Morii H Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452 [TBL] [Abstract][Full Text] [Related]
18. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines. Levy Y; Knutson JC; Bishop C; Shany S Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403 [TBL] [Abstract][Full Text] [Related]
19. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway. Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D affects proliferation of a murine T helper cell clone. Lacey DL; Axelrod J; Chappel JC; Kahn AJ; Teitelbaum SL J Immunol; 1987 Mar; 138(6):1680-6. PubMed ID: 3029220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]